On November 17, 2021, it was announced that Variational AI, a Vancouver-based life sciences company, closed its US$3.5 million Seed Funding round led by Seattle-based Flying Fish Ventures, Alliance of Angels and A&E Investments, with participation from Lip-Bu Tan and Amarjit Gill, Silicon Valley entrepreneurs, investors and advisors.
Variational AI is a developer of state-of-the-art generative AI technology to redefine the economics of drug development by accelerating the discovery of novel and optimized small molecules. The seed funding will enable Variational AI to accelerate existing discovery programs for COVID-19, cancer and other disease areas. The company will also utilize the new capital to hire additional leaders in medicinal chemistry, cheminformatics, and machine learning, and recruit a Scientific Advisory Board.
Osler advised Variational AI with a team consisting of Mark Longo, Riley Graydon, Tara Folk, Sylvia Rowat (Emerging & High Growth), Jun Lee (Corporate), Shaun Parker and Abigail Ywaya (Employment & Labor).